Distribuzione geografica
Continente #
NA - Nord America 6.297
EU - Europa 3.349
AS - Asia 629
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 4
AF - Africa 3
OC - Oceania 2
Totale 10.292
Nazione #
US - Stati Uniti d'America 6.268
UA - Ucraina 780
IE - Irlanda 537
SE - Svezia 503
IT - Italia 439
DE - Germania 349
DK - Danimarca 281
TR - Turchia 253
GB - Regno Unito 170
FI - Finlandia 156
KR - Corea 147
SG - Singapore 145
BE - Belgio 90
CN - Cina 61
CA - Canada 29
FR - Francia 17
PL - Polonia 16
IN - India 11
EU - Europa 7
RS - Serbia 7
JP - Giappone 4
IR - Iran 3
EC - Ecuador 2
EG - Egitto 2
HK - Hong Kong 2
NL - Olanda 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
BR - Brasile 1
CI - Costa d'Avorio 1
CL - Cile 1
CZ - Repubblica Ceca 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
VN - Vietnam 1
Totale 10.292
Città #
Chandler 918
Jacksonville 807
Fairfield 575
Dublin 536
Ashburn 377
Wilmington 290
Des Moines 287
Woodbridge 268
Boardman 239
Houston 232
New York 218
Cambridge 188
Centro 182
Seattle 175
Lawrence 174
Princeton 174
San Mateo 166
Ann Arbor 165
Brussels 90
San Diego 75
London 46
Turin 45
Beijing 41
Washington 32
Ottawa 26
Marche 18
Redmond 16
Kilburn 15
Norwalk 15
Kraków 13
Torre Annunziata 12
Pune 11
Helsinki 10
Ancona 9
Chiswick 9
Izmir 9
Civitanova Marche 8
Milan 8
Belgrade 7
Guangzhou 7
Prescot 7
Falls Church 6
Los Angeles 6
Senigallia 6
Acton 5
Boydton 5
Castelfidardo 5
Hounslow 5
Jesi 4
Lunano 4
New Bedfont 4
Porto 4
Redwood City 4
Bari 3
Falerone 3
Islington 3
Nanjing 3
Naples 3
Palermo 3
Rosora 3
Appignano 2
Auburn Hills 2
Bologna 2
Casoria 2
Florence 2
L’Aquila 2
Perugia 2
Southend 2
Tappahannock 2
Venice 2
Abbiategrasso 1
Abidjan 1
Acquaviva Picena 1
Amsterdam 1
Andover 1
Ariccia 1
Ascoli Piceno 1
Auckland 1
Baricella 1
Bitola 1
Bristol 1
Brno 1
Chicago 1
Cuenca 1
Dallas 1
Denver 1
Falkenstein 1
Fiano 1
Gambettola 1
Genoa 1
Genova 1
Haiphong 1
Hanover 1
Harbin 1
Hefei 1
Islamabad 1
Kagoya 1
Lequile 1
Limerick 1
Memphis 1
Totale 6.629
Nome #
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 125
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 113
Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals 97
Hepatitis E in a region of Italy: An emerging autochthonous infection? 97
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 95
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. 95
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 94
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 93
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 92
Descriptive epidemiology of cholangiocarcinoma in Italy. 91
Clinical implications of novel aspects of biliary pathophysiology. 89
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 89
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 89
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 88
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 87
Ethyl caffeoate: Liquid chromatography–tandem mass spectrometric analysis in Verdicchio wine and effects on hepatic stellate cells and intracellular peroxidation 86
Plasma membrane order parameter in periportal and perivenular hepatocytes isolated from ethanol-treated rats. 86
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 85
Primary biliary cirrhosis: modalities of injury and death in biliary epithelium. 84
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 83
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 82
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells. 81
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 81
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 80
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 79
Fibrogenic effect of oxidative stress on rat hepatic stellate cells. 77
Ethyl caffeate from Verdicchio wine: chromatographic purification and in vivo evaluation of its antifibrotic activity. 77
Transforming growth factor beta 1 increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. 76
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 76
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 75
Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. 74
Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. 74
VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study 73
Leptin enhances cholangiocarcinoma cell growth. 73
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 73
Current targets for Primary Sclerosing cholangitis 73
null 72
Postoperative recurrence of crohn’s disease: Pathophysiology, diagnosis and treatment 72
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. 71
Biologic Drugs in Crohn's Disease and Ulcerative Colitis: Safety Profile 71
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 71
Observer agreement in endoscopic assessment of ulcerative colitis. 70
Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. 70
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 70
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 70
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 70
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 70
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. 69
The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management 69
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 68
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 68
Aging and the Biological Response to Liver Injury 68
Vitamin E in chronic liver diseases and liver fibrosis. 67
Age and sex related changes of plasma membrane fluidity in isolated rat hepatocytes 67
Glucagon-like peptide-1receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced bya high-fat diet in nonalcoholic steatohepatitis 67
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 67
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct ligated rats 66
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency 66
The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. 66
Scelte terapeutiche e trattamento con sorafenib nell'epatocarcinoma: Analisi finale dello studio GIDEON in Italia 66
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 66
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 65
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 65
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 65
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 64
Mycosis Fungoides-like Eruption and Infliximab 64
Regulation of intracellular pH in isolated periportal and perivenular rat hepatocytes. 63
Evidence that plasma membrane fluidity of isolated hepatocytes is modified by exposure to microtubule-depolymerizing drugs 63
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. 63
Inhibition of the NA(+)/H(+) exchanger reduces rat hepatic stellate cell activity and liver fibrosis: an in vitro and in vivo study. 63
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation 62
Endoscopy Units and the Coronavirus Disease 2019 Outbreak: A Multicenter Experience From Italy 62
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 61
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 61
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 61
[Cholestasis. Recent diagnostic and therapeutic acquisitions]. 60
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 59
Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells. 59
Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells. 59
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. 59
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 58
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. 58
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 58
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 57
Endogenous opioid peptides and chronic liver disease: from bedside to bench. 57
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. 57
Quantitative study of apoptosis in normal rat gastroduodenal mucosa. 57
The significance of genetics for cholangiocarcinoma development 57
Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt 56
Morphological features and modulation of the intrahepatic biliary epithelium. 56
A quantitative evaluation of apoptotic bodies in rat liver. 56
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 56
Oxidative damage and celiac disease: role of the enzyme paraoxonase associated with high-density lipoprotein (HDL) 56
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 55
Subcellular changes and apoptosis induced by ethanol in rat liver. 55
Modification of lipid composition of erythrocyte membranes in chronic alcoholism. 55
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 55
Effect of cyanidin 3-O-β-glucopyranoside on hepatic stellate cell proliferation and collagen synthesis induced by oxidative stress 55
Totale 7.107
Categoria #
all - tutte 51.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.766

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 0 0 0 0 6 6 11 22 13
2019/20201.006 7 3 161 2 158 5 164 0 173 31 57 245
2020/20212.374 147 256 326 70 255 138 221 157 226 201 226 151
2021/20221.435 82 370 23 55 11 64 86 101 74 155 143 271
2022/20232.773 228 285 187 216 190 521 12 174 692 29 163 76
2023/20241.399 302 66 97 269 303 300 31 31 0 0 0 0
Totale 10.544